Health

Legend Capital led a $150m series E round for ClinChoice while Wemix took part in a $31.8m round for Planetarium Labs.

Mitsui Chemicals’ newly formed $36.8m 321Force unit will focus on healthcare, mobility, ICT and sustainable materials.

The debt finance deal gives FTX the chance to buy crypto management tool developer BlockFi for up to $240m - less than 10% of its last valuation - and the news should be making equity investors nervous.

We've condensed down three days of talks, networking and demos at the GCVI Summit in Monterey into these insights.

The nine-year Philips veteran is joining Ascension Ventures as medtech and life sciences investment leader.

The management change comes as OSF Ventures launches its third and biggest fund to date.

Three carmakers helped semiconductor producer CanSemi raise $670m while 574 Invest, RATP Group and Groupe Chopard backed a $167m round for vehicle charging network Electra.

Chanel and Kraft Group were among the investors in Evolved By Nature’s $120m series C round, while Prosus led a $39m series B for Sharebite.

UT Southwestern Medical Center spinout ReCode Therapeutics has now raised a total of $200m in its series B round from investors including Osage University Partners.

Siemens and Volkswagen provided $450m for the latter's Electrify America subsidiary while Leaps by Bayer helped push ReCode Therapeutics‘ series B round to $200m.

If a CVC unit wants to bring in outside money, it needs a great track record, a unique angle and skin in the game.